America wants to waive patent protection for vaccines
But it will not have an immediate effect on supplies
AMERICA HAS long been the global protector-in-chief of intellectual property. But on May 5th it sought to tear up the rule book. “The extraordinary circumstances of the covid-19 pandemic call for extraordinary measures,” said Katherine Tai, the United States Trade Representative. To help battle the pandemic, the administration of President Joe Biden said it supported waiving some intellectual-property protections for vaccines. Jaws dropped—along with the share prices of vaccinemakers.
This article appeared in the Business section of the print edition under the headline “A shot in the arm”
Business May 8th 2021
- Berkshire Hathaway’s questionable performance and governance
- Can human creativity prevent mass unemployment?
- America wants to waive patent protection for vaccines
- Older consumers have learned new tricks in the pandemic
- Apple may win a court battle but lose a regulatory war
- Private equity is losing its mystique
From the May 8th 2021 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Business
Corporate America’s diversity wars are just getting started
Donald Trump’s attacks on DEI are causing huge headaches for bosses
What Elon Musk should learn from Larry Ellison
The founder of Oracle has demonstrated remarkable staying power
Football clubs are making more money than ever. Players not so much
For both teams and their top stars, it helps to have a brand
The allure of the company town
Lego, Corning and the survival of an old idea
From cribs to carriers, high-end baby products are in vogue
Demographic and technological changes are making infancy more expensive
No one gains from American tariffs on cars from Mexico and Canada
Donald Trump’s levy will hit his country’s carmakers hardest